# OnCo record chengdu-zenitar-biomedical-technology (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/chengdu-zenitar-biomedical-technology/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "chengdu-zenitar-biomedical-technology" ;
  schema:name "Chengdu Zenitar Biomedical Technology"@en ;
  schema:alternateName "Chengdu Zenitar Biomedical Technology Co., Ltd"@en ;
  schema:description "Chengdu Zenitar Biomedical Technology is a Chinese developer in Chengdu that sponsors 6 registered cancer trials of Purinostat and Purinostat Mesylate."@en ;
  schema:url <https://onco.cc/companies/chengdu-zenitar-biomedical-technology/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?spons=Chengdu%20Zenitar%20Biomedical%20Technology> ;
  onco:tag "ctgov-sponsor", "china", "registry-only" ;
  schema:addressCountry "CN" ;
  onco:drugs <https://onco.cc/drugs/flonoltinib/>, <https://onco.cc/drugs/purinostat/> ;
  onco:trials <https://onco.cc/trials/nct06431243/>, <https://onco.cc/trials/nct07011056/>, <https://onco.cc/trials/nct05563844/>, <https://onco.cc/trials/nct07232290/>, <https://onco.cc/trials/nct06485219/>, <https://onco.cc/trials/nct06484829/> .